← Open Payments lookup

GARY MILLER: Open Payments

NPI 1770503336 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$243 in 12 payments from 8 companies in 2025. Trend: 2023 $299 · 2024 $832 · 2025 $243

Food & beverage: $243
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$61
Otsuka America Pharmaceutical, Inc.3$49
Neurocrine BioSciences, Inc.2$47
Janssen Pharmaceuticals, Inc1$27
Teva Pharmaceuticals USA, Inc.1$22
Dentsply Sirona Inc1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14
Corium, LLC1$3

Products named: COBENFY, INGREZZA, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, X-SMART, ABILIFY MAINTENA, CAPLYTA.

Industry payments across TX — which companies pay providers there.